- Home
- GUG vs TKNO Comparison
GUG vs TKNO Comparison
Compare GUG & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GUG | TKNO |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.7M | 491.3M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GUG | TKNO |
|---|---|---|
| Price | $13.76 | $8.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $9.83 |
| AVG Volume (30 Days) | 86.6K | ★ 706.5K |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $13.54 |
| Revenue Next Year | N/A | $14.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $13.55 | $1.91 |
| 52 Week High | $16.46 | $9.48 |
Technical Indicators
Market Signals| Indicator | GUG | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 54.34 |
| Support Level | $13.55 | $6.61 |
| Resistance Level | $16.06 | $9.45 |
| Average True Range (ATR) | 0.18 | 0.68 |
| MACD | 0.00 | 0.14 |
| Stochastic Oscillator | 19.40 | 58.70 |
Price Performance
Historical ComparisonAbout GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The Fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The Fund represents a single operating segment. Its products are Mutual Funds, Wealth Management SMAS, Institutional SMAS, ETFS, UITS, UCITS, CIT, Closed-End Funds, Private Funds, Rydex Funds, and Variable Insurance Funds.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.